mhurhangee/ep-ind-claims huggingface dataset:
A skin cleansing composition comprising: a) abrasive particles present at a level of from about 0.1 %, 0.3 %, or 0.5 % to about 5 %, 8 %, or 10 %, or preferably from about 1 % to about 3 % by weight of the composition, wherein said abrasive particles have: i) a mean Circularity of from about 0.65, or 0.70 to about 0.80, 0.85 or 0.90 or preferably from about 0.65 to about 0.85, as determined according to ISO 9726-6:2008; ii) a mean Solidity from about 0.60, 0.65, 0.70, or 0.75 to about 0.90, 0.95, or 1.0, or preferably from about 0.85 to about 1.0, as determined according to ISO 9276-6:2008; and iii) a Biodegradable Rate of at least about 30 %, or about 35 %, or about 40 %, as determined after 28 days according to the Biodegradability Test as disclosed herein; and b) a dermatologically acceptable carrier. a) abrasive particles present at a level of from about 0.1 %, 0.3 %, or 0.5 % to about 5 %, 8 %, or 10 %, or preferably from about 1 % to about 3 % by weight of the composition, wherein said abrasive particles have: i) a mean Circularity of from about 0.65, or 0.70 to about 0.80, 0.85 or 0.90 or preferably from about 0.65 to about 0.85, as determined according to ISO 9726-6:2008; ii) a mean Solidity from about 0.60, 0.65, 0.70, or 0.75 to about 0.90, 0.95, or 1.0, or preferably from about 0.85 to about 1.0, as determined according to ISO 9276-6:2008; and iii) a Biodegradable Rate of at least about 30 %, or about 35 %, or about 40 %, as determined after 28 days according to the Biodegradability Test as disclosed herein; and i) a mean Circularity of from about 0.65, or 0.70 to about 0.80, 0.85 or 0.90 or preferably from about 0.65 to about 0.85, as determined according to ISO 9726-6:2008; ii) a mean Solidity from about 0.60, 0.65, 0.70, or 0.75 to about 0.90, 0.95, or 1.0, or preferably from about 0.85 to about 1.0, as determined according to ISO 9276-6:2008; and iii) a Biodegradable Rate of at least about 30 %, or about 35 %, or about 40 %, as determined after 28 days according to the Biodegradability Test as disclosed herein; and b) a dermatologically acceptable carrier.
A method of determining a filling level of a product contained in a tank, the method comprising the steps of: a) transmitting an electromagnetic probing signal towards a target area of a surface of said product; b) receiving a reflected probing signal being a reflection of the electromagnetic probing signal at said surface; c) determining a parameter value indicative of an amplitude of the reflected probing signal; if said parameter value is indicative of an amplitude larger than a predetermined threshold value: d) transmitting an electromagnetic measuring signal towards said target area of the surface; e) receiving a return signal being a reflection of the electromagnetic measuring signal at the surface; and f) determining the filling level based on a time relation between said electromagnetic measuring signal and said return signal; and if said parameter value determined in step c) is indicative of an amplitude smaller than or equal to said predetermined threshold value, returning to step a); wherein said probing signal is shorter than said measuring signal. a) transmitting an electromagnetic probing signal towards a target area of a surface of said product; b) receiving a reflected probing signal being a reflection of the electromagnetic probing signal at said surface; c) determining a parameter value indicative of an amplitude of the reflected probing signal; d) transmitting an electromagnetic measuring signal towards said target area of the surface; e) receiving a return signal being a reflection of the electromagnetic measuring signal at the surface; and f) determining the filling level based on a time relation between said electromagnetic measuring signal and said return signal; and
A dialysis system comprising: an infusion system configured to infuse an infusion volume of dialysis solution into a patient; a drainage system configured to drain fluid from the patient into a drain container; a controller configured to: identify an indicator that a drain is complete; determine a drain volume of the fluid in the drain container; determine a minimum drain volume, wherein the minimum drain volume is a predetermined percentage of an expected drain volume, wherein the expected drain volume comprises the infusion volume and an estimated residual patient volume; and determine if the drain volume is less than the minimum drain volume. an infusion system configured to infuse an infusion volume of dialysis solution into a patient; a drainage system configured to drain fluid from the patient into a drain container; a controller configured to: identify an indicator that a drain is complete; determine a drain volume of the fluid in the drain container; determine a minimum drain volume, wherein the minimum drain volume is a predetermined percentage of an expected drain volume, wherein the expected drain volume comprises the infusion volume and an estimated residual patient volume; and determine if the drain volume is less than the minimum drain volume. identify an indicator that a drain is complete; determine a drain volume of the fluid in the drain container; determine a minimum drain volume, wherein the minimum drain volume is a predetermined percentage of an expected drain volume, wherein the expected drain volume comprises the infusion volume and an estimated residual patient volume; and determine if the drain volume is less than the minimum drain volume.
A printer configured to perform printing on a printing medium having an RFID, the printer comprising: a communication unit that includes a communicator configured to communicate with an IC chip of the RFID; and a detection unit configured to detect the printing medium using detection light, wherein the detection unit includes: a light emitter configured to emit the detection light; and a light receiver configured to receive the detection light through the printing medium, characterized in that the communicator is provided to be movable in a predetermined area along a conveyance surface of the printing medium, the light emitter is arranged outside the area in which the communicator is movable; the detection unit further includes a light guiding member configured to guide the detection light, emitted from the light emitter, to the printing medium; the light guiding member is provided between the light receiver and the communication unit extending in the area in which the communicator is movable, in the width direction of the printing medium; and the communication unit is arranged below and adjacent to the detection unit. a communication unit that includes a communicator configured to communicate with an IC chip of the RFID; and a detection unit configured to detect the printing medium using detection light, wherein the detection unit includes: a light emitter configured to emit the detection light; and a light receiver configured to receive the detection light through the printing medium, characterized in that the communicator is provided to be movable in a predetermined area along a conveyance surface of the printing medium, the light emitter is arranged outside the area in which the communicator is movable; the detection unit further includes a light guiding member configured to guide the detection light, emitted from the light emitter, to the printing medium; the light guiding member is provided between the light receiver and the communication unit extending in the area in which the communicator is movable, in the width direction of the printing medium; and the communication unit is arranged below and adjacent to the detection unit. a light emitter configured to emit the detection light; and a light receiver configured to receive the detection light through the printing medium, characterized in that the communicator is provided to be movable in a predetermined area along a conveyance surface of the printing medium, the light emitter is arranged outside the area in which the communicator is movable; the detection unit further includes a light guiding member configured to guide the detection light, emitted from the light emitter, to the printing medium; the light guiding member is provided between the light receiver and the communication unit extending in the area in which the communicator is movable, in the width direction of the printing medium; and the communication unit is arranged below and adjacent to the detection unit.
Base plate with sub-plates and receiving chambers offset in rows and columns with respect to each other, wherein the receiving chambers on the underside of the base plate have side walls which terminate with a base, and wherein the said sub-plates and the receiving chambers are so disposed that sub-plates or the receiving chambers are arranged in all the corner regions of the base plate, wherein, sub-receiving chambers with a half cross-section are connected to the receiving chamber sub-plates with a half cross-section for connecting identically-formed base plates on all outer sides (A, B, C, D) of the base plate connected to the sub-plates,, wherein the sub-receiving chambers are provided with side walls (18, 19, 20) extending outwards via the underside of the base plate to form the base anchor, characterized in that straps are formed on the outside of the extended side walls (18, 19, 20) on two adjacent identical outer sides (A, B) of the base plate, which are positioned to completely encircle the inserted extended sidewalls of sub-receiving chambers of an associated identically-formed base plate, wherein the side walls of the ground anchor brace both base plates and secure the base plates against tilting in a rigid unit.
Method for introducing a unique and selectable SNP in a marker associated with a trait in a non-human organism comprising the steps of: - selecting a trait of interest; - determining a locus that is associated with the trait; - determining the genetic map position of the locus; - identifying a marker that is located within a genetic distance from the locus wherein the genetic distance of the marker is at most 2 cM from the locus for a single marker and at most 10 cM in the case of two or more markers from the locus; - providing a population of the organism wherein each member of the population contains the marker(s); - determining the nucleotide sequence of the marker(s) for each of the members of the population; - aligning the nucleotide sequences of the markers; - selecting at least one position in the sequence of the markers that contain the same nucleotide in all markers of the population; - designing an oligonucleotide that is capable of hybridising to the marker sequence adjacent to both sides of the at least one position and wherein the oligonucleotide further contains a nucleotide (the marker nucleotide) at the at least one position that is different from the nucleotide at the at least one position in the marker; - introduce the marker nucleotide in the DNA of the organism using targeted nucleotide exchange with the oligonucleotide, thereby introducing a unique and selectable SNP in a marker associated with a trait. - selecting a trait of interest; - determining a locus that is associated with the trait; - determining the genetic map position of the locus; - identifying a marker that is located within a genetic distance from the locus wherein the genetic distance of the marker is at most 2 cM from the locus for a single marker and at most 10 cM in the case of two or more markers from the locus; - providing a population of the organism wherein each member of the population contains the marker(s); - determining the nucleotide sequence of the marker(s) for each of the members of the population; - aligning the nucleotide sequences of the markers; - selecting at least one position in the sequence of the markers that contain the same nucleotide in all markers of the population; - designing an oligonucleotide that is capable of hybridising to the marker sequence adjacent to both sides of the at least one position and wherein the oligonucleotide further contains a nucleotide (the marker nucleotide) at the at least one position that is different from the nucleotide at the at least one position in the marker; - introduce the marker nucleotide in the DNA of the organism using targeted nucleotide exchange with the oligonucleotide, thereby introducing a unique and selectable SNP in a marker associated with a trait.
A gas turbine engine component, comprising: a wall; and a lattice structure inside the wall and configured to communicate a cooling fluid therethrough, the lattice structure including a plurality of nodes and a plurality of branches that extend between the nodes, wherein a plurality of passages are defined between the plurality of branches and the plurality of nodes; wherein at least one branch of the plurality of branches is hollow and extends between adjoining hollow nodes of the plurality of nodes, wherein the at least one branch extends in a curved shape between the adjoining nodes; characterized in that at least one of the branches comprises a taper along a length thereof; and where the at least one branch of the plurality of branches comprises a first end and a second end, wherein the first end is connected to a first node of the adjoining nodes and the second end is connected to a second node of the adjoining nodes, wherein the curved shape extends along an entire length of the at least one branch from the first end to the second end. a wall; and a lattice structure inside the wall and configured to communicate a cooling fluid therethrough, the lattice structure including a plurality of nodes and a plurality of branches that extend between the nodes, wherein a plurality of passages are defined between the plurality of branches and the plurality of nodes; wherein at least one branch of the plurality of branches is hollow and extends between adjoining hollow nodes of the plurality of nodes, wherein the at least one branch extends in a curved shape between the adjoining nodes; characterized in that at least one of the branches comprises a taper along a length thereof; and where the at least one branch of the plurality of branches comprises a first end and a second end, wherein the first end is connected to a first node of the adjoining nodes and the second end is connected to a second node of the adjoining nodes, wherein the curved shape extends along an entire length of the at least one branch from the first end to the second end.
A system for passing an end portion of a needle system from a body cavity to an outer environment through a laparoscopic port, the system comprising at least one laparoscopic port, the port defining at least a first lumen and at least a seal mechanism across said lumen, the system further comprising: a needle instrument comprising a shaft and distal end portion; an elongated sleeve, comprising a second proximal opening, a second distal opening, a second lumen extending between said second proximal opening and said second distal opening, and a seal provided in said second lumen a seal bridge, comprising an elongated body; wherein said elongated sleeve is telescopically introducible through a first proximal end of said port, through said first lumen and bypassing said seal mechanism of said laparoscopic port; thereby bridging across and/or deactivating said seal mechanism; wherein said elongated body of said seal bridge comprises a distal opening and a lumen extending at least partially from said distal opening towards a proximal end of the seal bridge, the seal bridge lumen being sealed to gas at one end; and said seal bridge being adapted to be inserted through said second proximal opening to be deployed in said second lumen and thereby bridging across and/or deactivating said seal of said elongated sleeve; wherein said seal bridge lumen is adapted to receive said distal end portion of said needle shaft when said needle shaft enters said distal opening of said seal bridge. a needle instrument comprising a shaft and distal end portion; an elongated sleeve, comprising a second proximal opening, a second distal opening, a second lumen extending between said second proximal opening and said second distal opening, and a seal provided in said second lumen a seal bridge, comprising an elongated body; wherein said elongated sleeve is telescopically introducible through a first proximal end of said port, through said first lumen and bypassing said seal mechanism of said laparoscopic port; thereby bridging across and/or deactivating said seal mechanism; wherein said elongated body of said seal bridge comprises a distal opening and a lumen extending at least partially from said distal opening towards a proximal end of the seal bridge, the seal bridge lumen being sealed to gas at one end; and said seal bridge being adapted to be inserted through said second proximal opening to be deployed in said second lumen and thereby bridging across and/or deactivating said seal of said elongated sleeve; wherein said seal bridge lumen is adapted to receive said distal end portion of said needle shaft when said needle shaft enters said distal opening of said seal bridge.
A composition for use in providing contraception for an animal or human, the composition comprising: one or more substance(s) capable of forming a stimuli-responsive polymer mass in a reproductive body lumen of a subject; wherein the stimuli-responsive polymer mass is sufficient to occlude the reproductive body lumen in a manner that prevents transport of at least one cell through the reproductive body lumen; wherein the stimuli-responsive polymer mass is susceptible to reversal in the reproductive body lumen upon exposure to one or more stimuli such that after the reversal is performed, the stimuli-responsive polymer mass no longer occludes the reproductive body lumen; wherein at least one of the stimuli is light having a wavelength ranging from 200 nm to 2,500 nm, including from 250 nm to 450 nm, or from 300 nm to 425 nm, or from 330 nm to 420 nm, or from 350 nm to 390 nm, or from 365 nm to 405 nm, or from 330 to 460 nm, or from 370 to 440 nm, or from 405 nm to 500 nm, or from 500 nm to 800 nm, or from 700 nm to 2,500 nm. one or more substance(s) capable of forming a stimuli-responsive polymer mass in a reproductive body lumen of a subject; wherein the stimuli-responsive polymer mass is sufficient to occlude the reproductive body lumen in a manner that prevents transport of at least one cell through the reproductive body lumen; wherein the stimuli-responsive polymer mass is susceptible to reversal in the reproductive body lumen upon exposure to one or more stimuli such that after the reversal is performed, the stimuli-responsive polymer mass no longer occludes the reproductive body lumen; wherein at least one of the stimuli is light having a wavelength ranging from 200 nm to 2,500 nm, including from 250 nm to 450 nm, or from 300 nm to 425 nm, or from 330 nm to 420 nm, or from 350 nm to 390 nm, or from 365 nm to 405 nm, or from 330 to 460 nm, or from 370 to 440 nm, or from 405 nm to 500 nm, or from 500 nm to 800 nm, or from 700 nm to 2,500 nm.
An article of footwear comprising: an upper defining a cavity sized and shaped to receive a foot of a user, wherein the upper is attached to an outsole; and a protective toe cap positioned adjacent a toe region of the footwear, the toe cap being effective to protect a forefoot portion of the user's foot from injury and having an arcuate shape with a section arranged to overlie toes of the user's foot during use, wherein the toe cap has a forefoot side and a midfoot side and includes a ventilation channel for providing ventilation in the toe region, characterized in that the ventilation channel is defined in a protrusion extending from the midfoot side to the forefoot side, the protrusion having a height at a maximum at the midfoot side and decreasing in a direction of the forefoot side. an upper defining a cavity sized and shaped to receive a foot of a user, wherein the upper is attached to an outsole; and a protective toe cap positioned adjacent a toe region of the footwear, the toe cap being effective to protect a forefoot portion of the user's foot from injury and having an arcuate shape with a section arranged to overlie toes of the user's foot during use, wherein the toe cap has a forefoot side and a midfoot side and includes a ventilation channel for providing ventilation in the toe region, characterized in that the ventilation channel is defined in a protrusion extending from the midfoot side to the forefoot side, the protrusion having a height at a maximum at the midfoot side and decreasing in a direction of the forefoot side.
A hybrid vehicle comprising: an engine; a motor configured to output power for traveling; a drive wheel coupled to the engine and the motor; a transmission provided i) between the engine and the motor and ii) between the engine and the drive wheel, the transmission being configured to shift gears in a plurality of stages or continuously; a refrigerant supply device including a pump and a refrigerant pressure regulation device, the refrigerant supply device being configured to supply a refrigerant to the motor, and the refrigerant supply device being configured to supply the refrigerant to the transmission as a hydraulic fluid; and at least one electronic control unit configured to control the refrigerant supply device based on a load situation of the motor by controlling a refrigerant supply pressure to the motor, characterized in that the electronic control unit is configured to change a rotation speed of the engine such that a rotation speed of the drive wheel is kept constant when the refrigerant supply pressure to the motor is changed by the refrigerant pressure regulation device. an engine; a motor configured to output power for traveling; a drive wheel coupled to the engine and the motor; a transmission provided i) between the engine and the motor and ii) between the engine and the drive wheel, the transmission being configured to shift gears in a plurality of stages or continuously; a refrigerant supply device including a pump and a refrigerant pressure regulation device, the refrigerant supply device being configured to supply a refrigerant to the motor, and the refrigerant supply device being configured to supply the refrigerant to the transmission as a hydraulic fluid; and at least one electronic control unit configured to control the refrigerant supply device based on a load situation of the motor by controlling a refrigerant supply pressure to the motor, characterized in that the electronic control unit is configured to change a rotation speed of the engine such that a rotation speed of the drive wheel is kept constant when the refrigerant supply pressure to the motor is changed by the refrigerant pressure regulation device.
A subassembly (10.1) for a drug delivery device, the subassembly (10.1) comprising at least: - a housing (11, 20) adapted to contain a drug container, the drug container comprising a needle, - a cap, and - a spacer, - wherein the housing (11, 20) has an inner surface (11.4) forming a cavity (11.5) configured to retain the drug container, - wherein the cap is configured to be releasably connected to the housing (11, 20), and - characterised in that the spacer is arranged between the cap and the housing (11, 20), and configured to be placed between the cap and the housing (11, 20) or removed therefrom in a lateral direction. - a housing (11, 20) adapted to contain a drug container, the drug container comprising a needle, - a cap, and - a spacer, - wherein the housing (11, 20) has an inner surface (11.4) forming a cavity (11.5) configured to retain the drug container, - wherein the cap is configured to be releasably connected to the housing (11, 20), and - characterised in that the spacer is arranged between the cap and the housing (11, 20), and configured to be placed between the cap and the housing (11, 20) or removed therefrom in a lateral direction.